Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes
| Autor: | Cheri Deal, Charmian A. Quigley, Ron G. Rosenfeld, Alan G. Zimmermann, Gordon B. Cutler, Werner F. Blum, Christopher J. Child, Stenvert L. S. Drop |
|---|---|
| Přispěvatelé: | Pediatrics |
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty Adolescent Endocrinology Diabetes and Metabolism Thyrotropin 030209 endocrinology & metabolism Hypopituitarism Neuroendocrinology Short stature 03 medical and health sciences Sex Factors 0302 clinical medicine Endocrinology Hypothyroidism Internal medicine Congenital Hypothyroidism medicine Humans Child Human Growth Hormone business.industry Incidence (epidemiology) Age Factors General Medicine medicine.disease Congenital hypothyroidism Pituitary Hormones 030220 oncology & carcinogenesis Cohort Disease Progression Etiology IGHD Female medicine.symptom business Gonadotropins Follow-Up Studies |
| Zdroj: | European Journal of Endocrinology, 174(5), 669-679. Bioscientifica Ltd |
| ISSN: | 1479-683X 0804-4643 |
| Popis: | ObjectiveTo determine characteristics of children initially diagnosed with isolated growth hormone deficiency (IGHD) of organic aetiology, who later developed multiple pituitary hormone deficiencies (MPHD).DesignData were analysed for 716 growth hormone-treated children with organic IGHD, who were growth hormone-naïve at baseline in the multinational, observational Genetics and Neuroendocrinology of Short Stature International Study.MethodsDevelopment of MPHD was ascertained from investigator-provided diagnoses, adverse events and concomitant medications. Analyses were performed for all patients and separately for those who developed MPHD within 4.5 years or had >3.5 years follow-up and continued to have IGHD (4-year cohort).ResultsMPHD developed in 71/716 (9.9%) children overall, and in 60/290 (20.7%) in the 4-year cohort. The most frequent additional deficiencies were thyroid-stimulating hormone (47 patients) and gonadotropins (23 patients). Compared with those who remained with IGHD, children who developed MPHD had more severe GHD at study entry, significantly lower baseline insulin-like growth factor1, peak stimulated growth hormone, and more frequent diagnosis of intracranial tumour or mutation of gene(s) controlling hypothalamic–pituitary development and/or function. Multivariate logistic regression analyses identified female gender, longer follow-up, higher baseline age and lower peak stimulated growth hormone as predictors of MPHD development.ConclusionsMPHD is more likely to develop in patients with severe organic IGHD, especially those with history of intracranial tumour or mutation of gene(s) controlling hypothalamic–pituitary development and/or function. Older baseline age, female gender and longer follow-up duration were also associated with higher incidence of MPHD. Long-term monitoring of pituitary function is recommended, irrespective of the aetiology of GHD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|